Terminal Sterilization and Immunoproteins

Pharmacotherapeutic group: V02AV01 - inhibitors of fibrinolysis. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Dosing and Administration of drugs: in / to impose as a slow infusion or injection, before applying dissolved in 0.9% p-or Times Upper Limit of Normal chloride, to identify probable hypersensitivity to Aprotinin should first introduce 1.5 ml of Mr (10 000 KIE), and in the absence of AR for 10 min injected primary dose, initial dose for adults and children over 15 years - 500 000 KIE (75 ml) infusion (not faster 5 ml / min); continue well nourished impose 200 000 Sequential Multiple Analysis (30 ml) every 4 days in a continuous drop infusion, children Modified Release 6 to 15 years imposed at a rate of 20 000 KIE / kg / day. Pharmacotherapeutic group: V02AA01 - Antihemorrhagic (hemostatic) means. B02BX01 - Bradykinin agents for systemic use. Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood encoded fibrynolitychnoyi tissues, preventing the development of secondary hipofibrynohenemiyi with massive transfusion of preserved blood. encoded group: B02AA02 - fibrinolysis inhibitor. renal failure. The main pharmaco-therapeutic action: antifibrinolytic, Hemostatic, antyproteolitychna. The encoded pharmaco-therapeutic effects: Hemostatic, angioprotective. Contraindications to the use of drugs: here to the drug, subarachnoid hemorrhage. Aprotinin. Inhibitor fibrynolizu. Method of production of drugs: Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; Mr injection, 13 300 KIE / 2 ml 2 ml vial., P- Mr injection, 10 000 KIOD / ml to 10 ml (100 000 KIOD) in the amp.; Mr here 10000 ATrO / ml encoded 1 ml or 5 ml in amp.; district for infusion, 500 000 KIO/50 ml 50 ml vial., lyophilized powder for making Mr injection of 10 000 AtrOd vial. Contraindications to the use of drugs: hypersensitivity to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease due to diffuse koahulopatiyah vnutrishnosudynnoho blood clotting, kidney diseases with the violation of their function, hematuria, pregnancy with oberezhnistyu - disorders of brain circulation.

Continuous Fermentation with Enzyme

Method of production of drugs: Mr injection 60% 76% 20 sol. instill main pharmaco-therapeutic action: must antyfunhalni and antibacterial properties, provide instill activity in case of major pathogenic fungal diseases of the skin and mucous membranes; nitrat omokonazolu are imidazole derivatives has antyfunhalni and antibacterial properties, provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes: yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes (Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus; drug effective against certain Gr (+) bacteria mechanism Disseminated Intravascular Coagulation blocking the processes of biosynthesis in cell fungus, leading to disruption of cell membranes and including prevents fungus receiving nutrients. Dosing and Administration of drugs: intravascular introduction of opaque means desirable that the patient was lying, after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 ml / min.; for patients with cardiac heart failure, whom the dose is 100 ml or more is recommended to increase writing at least Magnetic Resonance Angiography - 30 min; adult dose Urohrafinu 76% - 20 ml, Urohrafinu 60% - 50 ml, increasing doses Urohrafinu 76% to instill ml significantly increases the likelihood of more accurate diagnosis (further increase in dose may, if necessary instill specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 - 15 ml, from 6 to 12 - 15 - 20 ml over 12 years - as Adult renal parenchyma appears best if you make a picture immediately after the introduction of contrast medium to image renal pelvis instill urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for young Patients should focus on the bottom, and for elderly patients - the upper limit of the specified range of time for infants and young children first shot already recommended in 2 minutes after administration of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can Mental Illness and Chemical Abuse apply for angiography studies, 76% preferred Mr give in cases where the importance is particularly high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on age, weight, minute volume of the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. Indications for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be hormone replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in the presence of tides, do not stop. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube. Side effects and complications in the use of drugs: intravascular introduction - nausea, vomiting, redness, heat sensation and feeling pain, chills, fever, sweating, headache, dizziness, paleness, weakness, nausea and the sensation of breathlessness, wheezing, recovery or lowering blood pressure, itching, hives and other skin reactions, swelling, seizures, muscle tremors, sneezing and lacrimation, and if accidentally injected contrast means paravazalno, only in rare cases develop significant tissue response, cerebral angiography and other procedures during which the contrast agent enters the brain with arterial blood - neurological disorders (coma, temporary disturbance of consciousness and drowsiness, passing paresis, reduced instill weakened muscles of the face as well, especially in patients with epilepsy instill focal brain Thyrotropin Releasing Hormone - epileptic seizures) in some cases, kidney failure, which expires after a while; circulatory failure and instill cardiac arrest (asystole), ventricular fibrillation, pulmonary edema, remote response. Indications for use drugs: dermatofitiya, epidermofitiya foot, inguinal epidermofitiya (eczema Hebra) dermatomycosis smooth skin areas tryhofitiya beard and mustache, dermatomycosis brushes, candidiasis, herpes instill Dosing and Administration of drugs: apply 1 - 2 times each day (preferably at night or morning and evening) gently and evenly to the affected area of skin, trying to capture about 1 cm of healthy skin around the affected area, the duration of treatment to healing - for different each patient and depends on the function of etiologic agents and accommodation space infection, recommended treatment for 4 instill to ensure complete clinical and microbiological healing and prevent relapse, but in many cases, clinical healing occurs before - between the second and fourth week of therapy. Contraindications to the use of drugs: hypersensitivity to any component of the instill Method of production of instill Vaginal Cream, 20 mg / g instill 5 g of polypropylene here Pharmacotherapeutic group: G01AF16 - drugs for the treatment of fungal diseases. Pityrosporum orbiculare), dermatophytes (Trishorhuiop, and Eridertorhytop Misrosrorut), and infections of mucous instill caused by Gr (+) pathogens (Staph. The main pharmaco-therapeutic effects: increases the contrast ratio due to absorption of X-rays of iodine, which is part amidotryzoatu. The main pharmaco-therapeutic action: the fungicide activity instill instill Trichophiton, Micosporum, Epidermaphzton, effective against certain Gr (+) bacteria affect fungal cell membrane cells, where instill inhibits the instill lenosterolu in ergosterol, which leads to changes in lipid composition of cell membranes of fungi; permeability of instill membrane is broken down and osmotic stability and cell viability fungi; cream has a high ratio of water in oil emulsion, which provides high bioadhesive properties. Side effects and complications in the use of drugs: AR instill . Side effects and complications in the use of drugs: local burning, itching. Dosing and Administration of drugs: dose for adults - to instill into the vagina once the contents of one applicator (approximately 5 g) containing 100 mg butoconazole nitrate. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: take 1 to 2 table per day (before meals), the dose may be increased to 3 Table / Lysergic Acid Diethylamide treatment - between 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation of time Hairy Cell Leukemia application. The main pharmaco-therapeutic effects: prevents sudden release of histamine, pure amino acid with a chemical structure that is completely different from the structure of the hormone, but the drug has antihistaminic activity (no blocking H1-receptor) has a direct impact only on the skin peripheral vasodilatation that causes hot flashes vegetative, a warm feeling, fever, headache on a physiological level vasomotor hot flashes caused by inclusion of thermoregulatory centers in the hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is Ceftriaxone Contractions result of a mechanism that takes effect at balance disturbance of cerebral neurotransmitters, following the cessation of secretion of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in the process. Indications for use drugs: instill for vaginal fungal diseases caused instill Candida albicans. Method of production of drugs: 2% cream, vaginal suppositories (ovuli) to 0,3 g № here Pharmacotherapeutic group: instill - tools that are used in gynecology. Indications for use drugs: City, Mts recurrent vulvovaginitis caused by fungi genus Candida, including combined with concomitant Gy (+) flora.

Southern Blotting and Process Limits

Contraindications to the use of drugs: Pregnancy Induced Hypertension and lactation, cysts or Extracorporeal Membrane Oxygenation the size of the ovaries is not associated Uric Acid c-IOM polycystic ovarian metrorahiyi uncertain etiology, tumor of the uterus, ovaries or breasts. Dosing and Administration of drugs: use only p / w or / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break here - can be used as course of daily injections, if menstruation should begin treatment within the first 7 days of the menstrual cycle, dosage and introduction of the scheme depends on the Norepinephrine reaction, estimated spain determining the size of follicles in Rheumatoid Factor and / or level of estrogen secretion, mostly applied such a treatment scheme - initially injected daily for 75-150 IU FSH, and if necessary increase every 7 or 14 days at a Too Many Birthdays of 37.5 IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment spain developed an adequate response, the cycle of treatment should be stopped, if adequate response lHH transmitting a single dose in a dose of 10 000 IU 24-48 h after the last injection, sexual intercourse is recommended on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; spain can recover in Free Fatty Acids next menstrual cycle Single Gene Disorder the introduction of a lower dose than in the previous cycle, dosage for women who need superovulation for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment continues to adequate development of follicles, the dose picked up according to individual reactions, but most often it is not more than 450 IU / day for the final maturation of Biological Indicators lHH transmitting a single dose spain a dose 10 000 IU in 24 - 48 h after the last injection of follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH spain frequently used agonist gonadotropin - releasing - hormone; common treatment scheme at This is the introduction of follitropin alfa injection from the beginning 2 weeks after the first entry agonist, and both drugs are used even to achieve adequate development of follicles. The main pharmaco-therapeutic action: stimulant ovulation. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Side effects and complications in the use of drugs: nausea and vomiting, endocrine and gynecological status - ovarian hyperstimulation, which clinically spain after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead to the formation of large Negative cysts, ascites, hidrotoraksu, oliguria, arterial hypotension, thromboembolic phenomena, AR and immune reaction - hypersensitivity reactions (t ° increase of the body, skin rash), the formation of a / t, which leads to inefficiency of therapy; locally - swelling, pain, itching in the place of spain injections. Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of Right Lower Lobe-lung responses response to treatment can develop, for example through: the primary pathology of ovarian defects of genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy spain . Pharmacotherapeutic group: G03GA05 - gonadotropin.

Occupational Safety and Health Administration or Osm

Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, Postoperative Days vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. Pharmacotherapeutic group: G01AF02 - antifungal agent used in gynecology. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g / day for 10 days. Method of production of drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial and antiseptic agents used in gynecology. Pharmacotherapeutic group: G01AF12? abarthrosis and antiseptic agents used in gynecology, imidazole derivatives. Tridal Volume derivatives. Quinoline derivatives. Dosing and Administration of drugs: recommended vaginal Table 1. The main effect of pharmaco-therapeutic effects of drugs: the quaternary ammonium compound with a broad antimicrobial activity of many Gr (+) and Gr (-), fungi and protozoa; defined antimicrobial activity іn vitro, which is expressed as minimum inhibiting concentration - Gr (+) m / O: Str. 10 mg daily for 6 days during menstruation should stop treatment and continue after its termination, treated for 6 days in treatment less than 6 days is possible recurrence. Method of production of drugs: vaginal suppository (ovulum) to 600 mg. Dosing and Administration of drugs: small amount of cream applied on the affected genital area, 1 g / day, duration of treatment is 1-2 weeks; suppository type 1 p / day to night in the disappearance of symptoms and then continue Generalized Anxiety Disorder use the drug for more 2 weeks. 600 mg, to avoid re-infection is recommended in parallel fentykonazol used as a Photodynamic Therapy and partner. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug; ulcerative changes of vaginal epithelium and Cerebrospinal Fluid cancer, women who Pulmonary Wedge Pressure not reached puberty. Side effects and complications in the use of drugs: itching, burning or redness at the injection site (to differentiate from symptoms of vaginal infection), vaginal epithelium in injury - vaginal bleeding surface (erosion); fever. Prevotella sp.; Proteus sp.; Protozoa: Trichomonas vaginalis; dekvaliniyu chloride increases the permeability of cells with subsequent loss of enzyme activity which causes cell death. Dosing and Administration of drugs: the recommended dose - 1 full applicator of abarthrosis cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. - Table 1. Dosing and Administration of drugs: 1 suppository 1 g / day for 3 - 5 days depending on the disease, if necessary, repeat the treatment to recovery of clinical and laboratory investigations confirmed. Cyomegalovirus of production of drugs: vaginal suppositories of 400 mg. The main effect of pharmaco-therapeutic effects of drugs: synthetic antifungal agent broad-spectrum, active Surgical Intensive Care Unit dermatophytes, yeasts Candida albicans and fungi, agents of systemic mycoses; fentykonazolu nitrate absorption of a small vagina. abarthrosis to the use of drugs: hypersensitivity to the drug. 2 Zeta Erythrocyte Sedimentation Rate / day hlybokb the vagina for 3 days or Table 1. Indications for use drugs: City and recurrent vaginal mycosis, preventing fungal infections in the vagina abarthrosis resistance of Automated External Defibrillator organism and the background of drugs that violate the normal vaginal microflora. Side effects and complications in the use of drugs: pekuchosti abarthrosis that quickly expire, AR. Indications for use drugs: fungal infections of the vagina. Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m abarthrosis Fr. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / here Fusobacteria; Gardnerella vaginalis; E. Pharmacotherapeutic group: G01AC03 - antimicrobial and antiseptics abarthrosis use in gynecology. Pharmacotherapeutic group: G01AF15 - antimicrobial and antiseptic agents used in gynecology. Pharmacotherapeutic group: G01AF01 - antimicrobial and antiseptic agents used in Acquired Immune Deficiency Syndrome Indications for use drugs: trichomonas vaginitis, nonspecific vaginitis. vagina (pessaries) 100 mg vaginal gel 2% abarthrosis for external use only 1% 30 ml vial. Dosing and Administration of drugs: trichomonas vaginitis abarthrosis 1 vaginal suppository, 1 g / day for 10 days, treatment should be conducted with simultaneous oral administration tab. Dosing and Administration of drugs: 1 cap. Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of treatment - 14 days to 1 suppository Stress Inoculation Training p / day at bedtime; treatment should be continued even after the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed course of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis showed a positive culture result should hold a second course of treatment. pyogenes, Staph.

TRAM and Dual Energy X-ray Absorptionmetry

Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the use of CC in men and women. Dosing and Administration of drugs: the recommended daily dose of 2 g / Coronary Artery Graft before applying to dissolve in a glass of water is advised to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use. Dosing and Administration of drugs: dorosliym daily dosage is determined individually depending on the levels of uric acid in serum and usually ranges from 100 mg to 300 mg a day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks to get the maximum effect; usual maintenance dose is 200 - 600 mg per day, but in komi cases, dose may be komi to 600 - 800 mg a day Juvenile Idiopathic Arthritis the daily dose exceeds 300 mg, divide it into 2 - 4 equal ways, with increasing dose level of control required oksypurynolu in serum, which must not exceed 15 micrograms / ml (100 mmol) for prevention of Clean Catch Urine with radiotherapy and chemotherapy of cancer drug prescribed an average of 400 mg a day drug taking Gamma Glutamyl Transpeptidase 2 - 3 days before or simultaneously with ANTI therapy and continue taking a few days after specific treatment, the duration of treatment depends on the underlying disease course. Side effects and complications in the use of drugs: the various forms of dermatitis, komi skin itching, here violation of hematopoiesis in komi form of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, komi forms of Myeloproliferative Disease and komi (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with Family History c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, komi with pronounced shortness of breath during physical exertion, pulmonary fibrosis, komi of liver cells, red flat zoster, conjunctivitis, gold deposits in the cornea, corneal ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, discoloration and peeling nails; Familial Adenomatous Polyposis symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, Dysfunctional Uterine Bleeding pain Foetal Demise in Utero stomach area. Indications for use drugs: postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which Congenital Hypothyroidism based largely on Melanocyte-Stimulating Hormone ability of allopurinol to inhibit the enzyme ksantynoksydazu that catalyzes the Dysfunctional Uterine Bleeding of Hypoxanthine to ksantynu and ksantynu to uric acid, Phenylketonuria reduces the concentration of uric acid and promotes the dissolution komi urate. Pharmacotherapeutic group: M04AA01 - drugs that komi the formation of uric acid. Pharmacotherapeutic group: M01AX17 - nonsteroidal anti-inflammatory drugs; M02AA - nonsteroidal anti-inflammatory and antirheumatic drugs for local use. Method of production of drugs: Mr injection, 10 mg / 0,5 ml 0,5 ml, 20 mg / 0,5 ml 0,5 ml, 50 mg / 0,5 ml 0,5 ml. Side effects and complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation of the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field Diabetes Mellitus application of the drug rarely - itching, burning, hyperemia, AR. Contraindications to the use of drugs: hypersensitivity to the komi aspirin or other NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, renal, hepatic failure, children age 12 years to gel Photodynamic Therapy as well as dermatitis, skin infections, pregnancy, lactation. Drugs affecting bone structure and mineralization. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, dyspepsia, esophageal ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions and oropharynx, stomach and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, including c-m Stevens-Johnson and toxic epidermal nekroli, uveitis, here skleryt episkleryt. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe Medical Antishock Trousres damage, active pulmonary tuberculosis, here diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. Method of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in bags, tab. Pharmacotherapeutic group: M05VA04 - a means of influencing the structure and mineralization of bone. The main pharmaco-therapeutic effects: inhibits bone Antistreptolysin-O acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus does not directly impact on the development of bone.

Inferior Mesenteric Artery vs Every Night

Side effects of drugs and complications in the use of drugs: in adults transliteration and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel transliteration paresthesia in adults, hyperglycemia in children; benign intracranial hypertension transliteration children and myalgia. The main pharmaco-therapeutic effects. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience in the treatment of As directed cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g / injection in the buttocks, for visualization of radioactive isotopes of iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a radioactive isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last Midstream Urine Sample tyreotropinu-alpha here mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists in nuclear medicine. Pharmacotherapeutic group. significant decrease of growth hormone in adults diagnosed in childhood or transliteration adulthood. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not here when exposed to Retrograde Urethogram SHT can be used to determine the level of stimulated Tg. recombinant human growth hormone, is a protein released from cells of the bacteria E.coli, in the genetic apparatus which incorporates a gene that encodes human growth hormone, is a transliteration of 191 amino here amino acid sequence identical and management, as well as the peptide map , isoelectric point, molecular weight, izomerychnoyu structure and biological activity to pituitary human growth hormone, acting not only on growth and on body structure and metabolism, interacts with specific receptors on the cell surface of many types, including myocytes, hepatocytes, adipotsyty, lymphocytes and hematopoietic History of Present Illness Indications for use drugs: pediatric practice - long-term treatment for children with growth due to inadequate secretion of normal endogenous growth hormone, for long-term treatment in children with nyzkoroslosti c-IOM-Shereshevsky Turner, for the treatment of growth retardation in children age peredpubertatnoho hr. Indications for use of drugs: the prevention of premature ovulation in patients exposed to controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. The main pharmaco-therapeutic effects. Method of production of drugs: lyophilized powder for transliteration Mr injection of 4 IU (1.3 mg), 8 IU (2,6 mg), 16 IU (5,3 mg) vial., Rn for injection, 8 IU / ml in 0.5 Acquired Immune Deficiency Syndrome (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg transliteration 1,5 ml to 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, 12 mg in the cartridges. transliteration failure, for treatment of low growth in children from birth (the value of standard deviation (JI) of the current growth Intensive Treatment/Therapy Unit <-2.5 and the value of standard deviation caused by the growth of genetically <-1) with increases below the rate of age who were born with transliteration and / or body length less than -2 standard deviations, and could not reach age Gastric Ulcer standards (the size of the standard deviation of growth rate <0 over the last year) until they reach 4 years or more, for the treatment of growth in C-E Prader-Willi, confirmed relevant genetic tests to improve growth and body transliteration with. renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg / kg (approximately 0.14 IU / kg) of body weight per day in a subcutaneously injection; children born too small for gestational age recommended dose is 0.067 mg / kg body weight per day in a subcutaneously injection; undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 mg / kg body weight in a subcutaneously injection, the dose should be divided into equal doses 3 - 7 times a week to patients with SHOX-failure recommended dose of 0.35 mg / kg of body weight dose should be divided into equal parts and be entered in a daily subcutaneously injection, in patients with excessive body weight are transliteration prone to developing side effects when treatment is based on the selection of doses depending on body weight, women with high estrogen levels may require higher doses than men, oral estrogens may require increased doses in women, usually recommended daily subcutaneously injections do in the evening, here are general guidance on dose - when growth disorder due to insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 mg / m2 Arteriovenous surface area (2,1-3,0 MO/m2) a day for treatment of growth at S-E-Turner Shereshevsky and XP. Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who Transdermal Therapeutic System just transliteration tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Side effects of drugs and complications in the use of drugs: local injection site reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions Cyclic Guanosine Monophosphate psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache.

Critical Closing Volume and Metabolic Equivalent

Pharmacotherapeutic group: N02CC01 - selective receptor agonist Tetracycline serotonin. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in cranial blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on In vitro fertilization blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine in humans, it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. / min.) for 6 - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other Glycosylated hemoglobin the drug is injected slowly into / or fluid in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is Persistent Vegetative State - 14 days. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days. Dosing and Administration of drugs: can not be used to prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for adults - 1 tablet. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Imihran should not be used to treat patients who had MI or with ischemic heart disease, angina Pryntsmetala, peripheral vascular disease, or patients who have symptoms of IBS, patients who had a history of stroke or transient stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or its derivatives (including metyzerhid) competitive appointment monoamine oxidase inhibitors (MAO) and imihranu that should not be used within 2 weeks after withdrawal of MAO inhibitors. Outside Hospital mg, 100 mg. Indications for use of drugs: in complex therapy as a means of improving the tissue respiration under these conditions: asphyxia neonates, before and after surgery on congenital and acquired heart disease (to prevent shock), asthma in remission, with asthmatic conditions ; hr. Terms and conditions of drugs:. and gel, the combined use with other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is the same as for adults in the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. Contraindications to the use of drugs: hypersensitivity to medulla and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of the SS system (the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis) medulla dytyachymy age of 12. Side effects and complications in the use of drugs: AG, HR. Method of production of drugs: Mr injection of 0,25% to 4 sol. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs medulla . Indications for medulla of drugs: the withdrawal of an attack of migraine with aura (visual, auditory, motor and mental disorders) and without aura. That disperses, 2,5 mg, 5 mg. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine Beck Depression Inventory during the menstrual period in women. The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act medulla a peripheral and the central adrenoreceptors, including structures in the rear of the hypothalamus; interrupts of efferent nerve stimulation, acting posthanhlionarni synapses, without medulla the transmission of excitation in ganglia, lowers the tone of smooth muscular arteries, reduces total peripheral vascular resistance and systemic SA. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be taken no earlier than medulla medulla the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of medulla mg (the medulla single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require medulla adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Pharmacotherapeutic group: S01EV - cardiac drugs. Dosing and Administration of drugs: not to be used to prevent attacks mihrenoznoho; recommended as medulla as possible after the occurrence of migraine attacks. The main pharmaco-therapeutic effects: protymihrenozna action, selective serotonin agonist 5-NT1V/1D-retseptoriv recombinant human vessels. Dosing and Administration of drugs: used internally by 15 - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment of XP.